goes Russia A short company presentation. Who we are. What we do.

Slides:



Advertisements
Similar presentations
Applications of genome sequencing projects 1) Molecular Medicine 2) Energy sources and environmental applications 3) Risk assessment 4) Bioarchaeology,
Advertisements

applications of genome sequencing projects
Chapter 4: recombinant DNA
Principles and Practices of Biosafety Environmental Health and Safety San Diego State University.
BIOINFORMATICS CSMN 601 Zhongchun Wang. AGENDA What is Bioinformatics History Genome ABC Technology Industry Overview Ethical, Legal, and Social Implications.
Polymerase Chain Reaction WORKSHOP (3)
Institute of Biotechnology and Antibiotics (IBA) Presented by Małgorzata Kęsik Assistant Professor at IBA.
ENIVD 06/06 02:19 First international proficiency study on West Nile virus molecular detection. Matthias Niedrig, Sonja Linke Christian Drosten Hervé Zeller.
Biotechnology and Genetic Engineering. Human Cloning-The Science In The News.
Biotechnology and Recombinant DNA
Molecular Techniques in Microbiology These include 9 techniques (1) Standard polymerase chain reaction Kary Mullis invented the PCR in 1983 (USA)Kary.
Genetic Engineering Zino Morkache-Aerospace Department-MAE430.
Chapter 12 Lecture Outline Molecular Techniques and Biotechnology.
LECTURE CONNECTIONS 19 | Molecular Genetic Analysis and © 2009 W. H. Freeman and Company Biotechnology.
SmartGrid – a business unit of devolo AG Company Presentation Walter Krott – Director Sales SmartGrid SmartGrid.
Genetic Engineering/ Recombinant DNA Technology
9.1 Manipulating DNA KEY CONCEPT Biotechnology relies on cutting DNA at specific places.
Alexander Panin, director The All-Russian State Center for Quality and Standardization of Veterinary Drugs and Feed (VGNKI) Collaborating Center of the.
Overview Founded: 1963 in Vienna, Austria Activity: Distribution of products and services for Life Science, Research and Diagnostics Employees: 22 7 product.
Promega Corporation ©2014 Promega Corporation. Overview of Promega's Science and Business June 2015 Tom Livelli, VP Life Sciences.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Molecular Diagnostics Market to grow at 8.1% CAGR from 2016 to 2023
What is PCR? : Why “Polymerase”?
Lithuania: Biotechnology
MarketsandMarkets Presents
Center of Bioengineering, RAS
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Drug Discovery Informatics.
Protein Expression Market to Reach $3 billion by 2023.
Minimal Residual Disease (MRD) Detection Technologies
RTA in Brief 1996 – Founded, started distribution of Merial poultry vaccines – Made investments in R&D activities for human health – Moved.
DNA Marker Lecture 10 BY Ms. Shumaila Azam
National 5 Biology Genetic Engineering Mr G Davidson.
Detection of genetically modified plants By: Ehsan Zayerzadeh Standard Research Institute
Synthetic Biology Market Global synthetic biology market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast.
Present By:- Company Name: Global Market Forecastes Tel: / Web:
MarketsandMarkets Presents Genotyping Market worth $17.0 Billion by html.
MarketsandMarkets Presents Technology Advancement in Genotyping Market html.
MarketsandMarkets Presents Increasing Demand for Affordable Genotyping Services by
Rise In Need Of Ligase Enzyme Market During 2018 To SIZE, TREND, SHARE, OPPORTUNITY ANALYSIS, AND FORECAST,
MarketsandMarkets Presents Forecast Market Share Estimation of Genotyping in Emerging Economies
MarketsandMarkets Presents Find out How the Value of Global Genotyping Market has changed over Time html.
MarketsandMarkets Presents Find out How the Value of Non Invasive Prenatal Testing Market has changed over Time html.
MarketsandMarkets Presents Non Invasive Prenatal Testing Market by Consumables Market Size, By Type, 2016 vs html.
MarketsandMarkets Presents Non Invasive Prenatal Testing (NIPT) Market Size, By Application and Forecast html.
MarketsandMarkets Presents Non Invasive Prenatal Testing (NIPT) Market Launch of New and Advanced Products html.
MarketsandMarkets Presents Genotyping Market: Geographic Growth Opportunities by html.
MarketsandMarkets Presents Non Invasive Prenatal Testing (NIPT) Market: intelligence, strategy & Global Forecast html.
MarketsandMarkets Presents Non Invasive Prenatal Testing (NIPT) Market: NGS Systems to Register the Highest CAGR in the NIPT Instruments Market from 2016.
MarketsandMarkets Presents Genotyping Market Share Analysis, By Key Players & Competitive Landscape html.
MarketsandMarkets Presents Genotyping Market: Scope & Application Market by Stakeholders and Geography and Global forecast html.
MarketsandMarkets Presents Non Invasive Prenatal Testing (NIPT) Market is expected to reach $2.88 Billion by 2021 at a CAGR of 16.4% html.
MarketsandMarkets Presents Increasing Incidences and Awareness of Genetic Diseases to Drive the Growth of Genotyping Market html.
MarketsandMarkets Presents Non Invasive Prenatal Testing (NIPT) Market worth $2.88 Billion by html.
Using Galaxy for Molecular Assay Design
Molecular Techniques and Biotechnology
With Genetic Analyzers from Applied Biosystems
MICROBIOLOGY Micro = small, bio = life and logo = study
Welcome To The Centre for Applied Genomics
Who is Quantabio?.
Measure Definition.
From genotypes to phenotypes
1.1.3 MI.
Polymerase Chain Reaction
Biotechnology Training & Researching in University of Natural Science
Bio-Rad Overview and Statement of Interests
Global DNA Sequencing Market
GLOBAL TRANSPLANT DIAGNOSTICS MARKET 2017 – 2025 Published by :Accurize Market Research Pvt. Ltd. Copyright © 2019 Accurize Market Research
Published by :Accurize Market Research Pvt. Ltd. Copyright © 2019 Accurize Market Research Global Microfluidic Devices.
Magdalena Kluska University of Lodz
Cancer/Tumor Profiling Market to Reach $87.1 Billion By 2023.
Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding and 20 Company Profile - Global Forecast to 2026
Presentation transcript:

goes Russia A short company presentation. Who we are. What we do. What we want. Competence and Service in Molecular Biology

Who we are Founded in September 1997 Located in Munich / Martinsried 100% privately owned Core business: DNA/RNA custom synthesis Besides oligos many “PCR relevant” products ISO 9001:2000 certified production International reputation as high quality custom DNA oligonucleotides “house” > 10.000 customers worldwide Competence and Service in Molecular Biology

What we do Core business: DNA/RNA custom synthesis Standard “every day”/modified oligonucleotides Real-time PCR probes (incl. LightCyclerTM Probes) Oligos in 96well plates for genotyping, etc. Standard products like enzymes, purification kits, … High quality guaranteed – Made in Germany Active worldwide – with focus on Europe, eastern Europe and Asia Competence and Service in Molecular Biology

Applications Which applications need high quality oligos? Human diagnostics Veterinary diagnostics Detection of pathogens (viruses, bacteria, parasites) SNP analysis/genotyping Paternity testing/proof of origin for plant and animal species “DNA Identification” Technologies Residual DNA Analysis Competence and Service in Molecular Biology

Applications Which applications need high quality oligos? Gene therapy distribution and expression assays Drug response analysis High-density probe arrays Expression systems development Cell bank copy number analysis Industrial microbiology Blood products quality control Competence and Service in Molecular Biology

What we want Help to develop good business relations between Russia and Germany Expansion of metabion’s presence in the Russian life-science market Become an integrated part of the Russian research society Become THE supplier of high-quality oligonucleotides in the Russian Federation Competence and Service in Molecular Biology

References Competence and Service in Molecular Biology Sequenom Inc. Nanogen GlaxoSmithKline Roche Diagnostics Wellcome Trust Center for Human Genetics, Oxford Central Public Health Laboratory, London Biotest AG Schering AG Joslin Diabetes Centre, Boston Harvard Medical School, Boston EMBL, Heidelberg & Italy Institut Pasteur, Paris DiagnoCure, Quebec City, Canada McGill University, Montreal Keygene NV, Netherlands Boehringer Ingelheim, Austria BASF Plant Science GmbH, Ludwigshafen Evotec Neurosciences GmbH, Hamburg Bayer AG Scienion AG, Berlin Qiagen GmbH, Hilden Robert-Koch Institut, Berlin GPC AG, Martinsried/Boston Morphosys AG, Martinsried/Charlotte MediGene AG, Martinsried/San Diego All Max-Planck Institutes in Germany Universities all over Germany and worldwide ... Competence and Service in Molecular Biology

Thank you! Competence and Service in Molecular Biology